SMA® Professional

The Importance of Human Milk Oligasaccharides (HMOs)
View in browser
INFORMATION FOR HEALTHCARE PROFESSIONAL USE ONLY

%%[ IF NOT EMPTY(@FirstName) THEN ]%% %%[ ELSE ]%% %%[ ENDIF ]%%

Hello %%=v(@FirstName)=%%,

Hello,

On the 17^th of November we will remember World Prematurity Day. We want to take this opportunity to honour all the healthcare professionals who dedicate their lives to the care of premature babies. Thanks to your commitment, preterm babies are given a fighting chance from the very beginning. We truly acknowledge your impact. Thank you.

Would you like to better understand what Human Milk Oligosaccharides (HMOs) are, why they are important and their benefits in preterm infants?

"EMPOWERING PREEMIES: THE IMPORTANCE OF HUMAN MILK OLIGOSACCHARIDES"

Webinar date: Thursday 20^th November 2025
Time: 7pm-8pm (BST)

Dr. Boutaina Zemrani is a paediatrician with expertise in paediatric nutrition, bringing over 15 years of clinical experience from university hospitals across Europe, Africa, and Australia.

This free, live interactive webinar is designed to support healthcare professionals by discussing the science and functional benefits of Human Milk Oligosaccharides (HMOs) and their importance in preterm infants. This webinar will give you an opportunity to hear from a leading researcher, Dr. Boutaina Zemrani, discussing:

- the science and functional benefits of Human Milk Oligosaccharides (HMOs),
- and their importance in preterm infants.

This 1-hour session will also include an interactive Q&A with the speaker.

Explore our free webinar library
Missed something? Don't worry, our library has a wealth of webinar content with expert advice to help support our healthcare members.

View library

® Registered Trademark.

IMPORTANT NOTICE: We believe that breastfeeding is the ideal nutritional start for babies and we fully support the World Health Organization’s recommendation of exclusive breastfeeding for the first six months of life followed by the introduction of adequate nutritious complementary foods along with continued breastfeeding up to two years of age. We also recognise that breastfeeding is not always an option for parents. We recommend that healthcare professionals inform parents about the advantages of breastfeeding. If parents consider not to breastfeed, healthcare professionals should inform parents that such a decision can be difficult to reverse and that the introduction of partial bottle-feeding will reduce the supply of breast milk. Parents should consider the social and financial implications of the use of infant formula. As babies grow at different rates, healthcare professionals should advise on the appropriate time for a baby to begin eating complementary foods. Infant formula and complementary foods should always be prepared, used and stored as instructed on the label in order to avoid risks to a baby’s health. The product should be used only on the advice of independent persons having qualifications in medicine, nutrition, pharmacy, or other professionals responsible for maternal and child care. • SMA Gold Prem^® 1 is a special formula intended for the dietary management of preterm low birthweight babies who are not solely fed breast milk. It is suitable for use as the sole source of nutrition for preterm babies from birth. SMA Gold Prem^® 1 is not intended for use with older preterm babies, for whom a special catch-up formula such as SMA Gold Prem^® 2 is more appropriate. • SMA Gold Prem^® 2 is a special catch-up formula intended for the dietary management of preterm low birthweight babies who are not solely fed breast milk. It is a nutritionally complete formula for use on discharge from hospital or when a low birthweight formula is no longer appropriate. It is suitable for use as the sole source of nutrition up to 6 months corrected age. SMA Gold Prem^® 2 is not intended for use with newborn preterm babies, for whom fortified breast milk or a low birthweight formula such as SMA Gold Prem^® 1 is more appropriate.

Contact SMA® Nutrition | Terms & conditions | Privacy Policy

Unsubscribe

ZTC8742/10/25